The Nanotech Company Co-Founder Wins 2005 Japan Prize

The companys Co-Founder and Scientific Advisory Board Chairman, Erkki Ruoslahti, M.D. PhD, will receive the 2005 Japan Prize.

San Diego, CA (PRWEB) January 13, 2005 --- The Nanotech Company, LLC, a leading small tech advisory firm, is proud that the companys Co-Founder and Scientific Advisory Board Chairman, Erkki Ruoslahti, M.D. PhD, will receive the 2005 Japan Prize. The award is given for his decisive role in elucidating the molecular mechanism of cell-to-extracellular matrix adhesion.

The Japan Prize (and cash award) is presented at a rare public appearance of the Emperor at the focus of a one-week celebration.

Dr. Ruoslahti said, I am thrilled and honored to be receiving this prestigious prize. It is in recognition of work done about 20 years ago when we showed that a 3 amino acid chemical motif is the key structure for cell attachment. Compounds that contain this so-called RGD peptide motif are used in the clinic to prevent blood clotting, and RGD drugs for other uses are under development. My particular current interest is to use RGD and other peptides to build 'smart' nanoparticles that can deliver drugs to tumors."

Darrell Brookstein, Managing Director and Co-Founder of The Nanotech Company, LLC said, This international award for scientific achievement and service to humanity is in recognition of Dr. Ruoslahtis work in biology. Many winners have been awarded the Nobel. We wish our SAB Chairman the heartiest of congratulations and look forward to the early results of his current nano-medicine work."

The Japan Prize is awarded for original and outstanding achievements in science and technology that are recognized as having advanced the frontiers of knowledge and served the cause of peace and prosperity for mankind.

The Nanotech Company, LLC

The Nanotech Company, LLC ensures that emerging small tech companies achieve their corporate development goals by accessing its significant scientific, corporate development, and financial advisory resources. Managing Director, Darrell Brookstein, a 30 year financial executive, and Erkki Ruoslahti, M.D., Ph.D., a Distinguished Professor and bionanoscientist, have assembled an eminent team of specialists to enhance and accelerate the intelligent growth of small tech companies.

The company publishes a free weekly e-digest of nanotech news, and Nanotech Fortunes. For information, visit http://www.nanotechnology.com.

Contact:

Darrell Brookstein

858-794-0848

# # #